Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases

Neurochemistry International

Volumn 89, Issue , 2015, Pages 198-208

  Pandareesh, M D ^a   Mythri, R B ^a   Srinivas Bharath, M M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Bioavailability; Blood brain barrier; Neurodegenerative diseases; Pharmacodynamics; Pharmacokinetics; Polyphenols

Indexed keywords

CURCUMIN; DIETARY POLYPHENOL; NUTRACEUTICAL; POLYPHENOL; RESVERATROL; UNCLASSIFIED DRUG; TEA;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; DRUG STABILITY; HUMAN; LIPOPHILICITY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TEA; ANIMAL; BIOAVAILABILITY; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; DIET THERAPY; DRUG EFFECTS; FRUIT; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VEGETABLE;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; FRUIT; HUMANS; POLYPHENOLS; TEA; VEGETABLES;

EID: 84942294613     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.07.003     Document Type: Review

References (212)

1. M.M. Abd El Mohsen, G. Kuhnle, A.R. Rechner, H. Schroeter, S. Rose, P. Jenner, and C.A. Rice-Evans Uptake and metabolism of epicatechin and its access to the brain after oral ingestion Free Radic. Biol. Med. 12 2002 1693 1702
2. S. Acharya, F. Dilnawaz, and S.K. Sahoo Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 29 2009 5737 5750
3. D. Albani, L. Polito, S. Batelli, S. De Mauro, C. Fracasso, G. Martelli, L. Colombo, C. Manzoni, M. Salmona, S. Caccia, A. Negro, and G. Forloni The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide J. Neurochem. 5 2009 1445 1456
4. D. Albani, L. Polito, A. Signorini, and G. Forloni Neuroprotective properties of resveratrol in different neurodegenerative disorders Biofactors 5 2010 370 376
5. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 6 2007 807 818
6. A. Anandhan, K. Tamilselvam, D. Vijayraja, N.A. Kumar, S. Rajasankar, and T. Manivasagam Resveratrol attenuates oxidative stress and improves behaviour in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice 2010 Place. Published
7. D.W. Anderson, K.A. Bradbury, and J.S. Schneider Neuroprotection in Parkinson models varies with toxin administration protocol Eur. J. Neurosci. 11 2006 3174 3182
8. C. Andres-Lacueva, B. Shukitt-Hale, R.L. Galli, O. Jauregui, R.M. Lamuela-Raventos, and J.A. Joseph Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory Nutr. Neurosci. 2 2005 111 120
9. R. Astarloa, M.A. Mena, V. Sanchez, L. de la Vega, and J.G. de Yebenes Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease Clin. Neuropharmacol. 5 1992 375 380
10. K. Azuma, K. Ippoushi, H. Ito, H. Higashio, and J. Terao Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats J. Agric. Food Chem. 6 2002 1706 1712
11. U. Bickel, T. Yoshikawa, and W.M. Pardridge Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Deliv. Rev. 1-3 2001 247 279
12. E.J. Bilsky, R.D. Egleton, S.A. Mitchell, M.M. Palian, P. Davis, J.D. Huber, H. Jones, H.I. Yamamura, J. Janders, T.P. Davis, F. Porreca, V.J. Hruby, and R. Polt Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability J. Med. Chem. 13 2000 2586 2590
13. M. Bishnoi, K. Chopra, L. Rongzhu, and S.K. Kulkarni Protective effect of curcumin and its combination with piperine (Bioavailability Enhancer) against Haloperidol-associated neurotoxicity: cellular and neurochemical evidence Neurotox. Res. 3 2011 215 225
14. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, A. Maitra, and A. Maitra Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy J. Nanobiotechnology 3 2007
15. J. Blanchet, F. Longpre, G. Bureau, M. Morissette, T. DiPaolo, G. Bronchti, and M.G. Martinoli Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice Prog. Neuropsychopharmacol. Biol. Psychiatry 5 2008 1243 1250
16. R.J. Boado, and W.M. Pardridge Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates Bioconjug Chem. 5 1994 406 410
17. M.G. Boersma, H. van der Woude, J. Bogaards, S. Boeren, J. Vervoort, N.H. Cnubben, M.L. van Iersel, P.J. van Bladeren, and I.M. Rietjens Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases Chem. Res. Toxicol. 5 2002 662 670
18. E. Bombardelli, S.B. Curri, R. Loggia Della, N.P. Del, A. Tubaro, and P. Gariboldi Complexes between phospholipids and vegetal derivatives of biological interest Fitoterapia 1989 1 9
19. G. Borges, S. Roowi, J.M. Rouanet, G.G. Duthie, M.E. Lean, and A. Crozier The bioavailability of raspberry anthocyanins and ellagitannins in rats Mol. Nutr. Food Res. 6 2007 714 725
20. J. Bournival, P. Quessy, and M.G. Martinoli Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons Cell. Mol. Neurobiol. 8 2009 1169 1180
21. D. Brewster, P.W. Dettmar, and G. Metcalf Biologically stable analogues of TRH with increased neuropharmacological potency Neuropharmacology 5 1981 497 503
22. N. Brondino, S. Re, A. Boldrini, A. Cuccomarino, N. Lanati, F. Barale, and P. Politi Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies ScientificWorldJournal 2014 174282
23. I. Brouet, and H. Ohshima Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages Biochem. Biophys. Res. Commun. 2 1995 533 540
24. E.A. Brownson, T.J. Abbruscato, T.J. Gillespie, V.J. Hruby, and T.P. Davis Effect of peptidases at the blood brain barrier on the permeability of enkephalin J. Pharmacol. Exp. Ther. 2 1994 675 680
25. P. Campos-Bedolla, F.R. Walter, S. Veszelka, and M.A. Deli Role of the blood-brain barrier in the nutrition of the central nervous system Arch. Med. Res. 8 2014 610 638
26. M. Cegnar, J. Kos, and J. Kristl Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles J. Nanosci. Nanotechnol. 9-10 2006 3087 3094
27. R. Cermak, and S. Wolffram The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms Curr. Drug Metab. 7 2006 729 744
28. J.M. Chan, L. Zhang, K.P. Yuet, G. Liao, J.W. Rhee, R. Langer, and O.C. Farokhzad PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 8 2009 1627 1634
29. M.M. Chan, H.I. Huang, M.R. Fenton, and D. Fong In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties Biochem. Pharmacol. 12 1998 1955 1962
30. J. Chao, W.K. Lau, M.J. Huie, Y.S. Ho, M.S. Yu, C.S. Lai, M. Wang, W.H. Yuen, W.H. Lam, T.H. Chan, and R.C. Chang A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine Neurosci. Lett. 3 2010 360 364
31. J. Chao, H. Li, K.W. Cheng, M.S. Yu, R.C. Chang, and M. Wang Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells J. Nutr. Biochem. 6 2010 482 489
32. J. Chao, M.S. Yu, Y.S. Ho, M. Wang, and R.C. Chang Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity Free Radic. Biol. Med. 7 2008 1019 1026
33. M.D. Chavanpatil, Y. Patil, and J. Panyam Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux Int. J. Pharm. 1-2 2006 150 156
34. C.Y. Chen, P.E. Milbury, K. Lapsley, and J.B. Blumberg Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation J. Nutr. 6 2005 1366 1373
35. D. Chen, Q.T. Li, and K.H. Lee Antinociceptive activity of liposome-entrapped calcitonin by systemic administration in mice Brain Res. 1 1993 139 142
36. J. Chen, X.Q. Tang, J.L. Zhi, Y. Cui, H.M. Yu, E.H. Tang, S.N. Sun, J.Q. Feng, and P.X. Chen Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway Apoptosis 6 2006 943 953
37. L. Chen, M.J. Lee, H. Li, and C.S. Yang Absorption, distribution, elimination of tea polyphenols in rats Drug Metab. Dispos. 9 1997 1045 1050
38. Y.R. Chen, and T.H. Tan Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin Oncogene 2 1998 173 178
39. E.G. Chikhale, K.Y. Ng, P.S. Burton, and R.T. Borchardt Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides Pharm. Res. 3 1994 412 419
40. J.Y. Choi, C.S. Park, D.J. Kim, M.H. Cho, B.K. Jin, J.E. Pie, and W.G. Chung Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate Neurotoxicology 3 2002 367 374
41. B. Cimrova, S. Budac, U. Melicherova, M. Jergelova, and F. Jagla Electrophysiological evidence of the effect of natural polyphenols upon the human higher brain functions Neuro Endocrinol. Lett. 4 2011 464 468
42. V. Crespy, C. Morand, C. Besson, C. Manach, C. Demigne, and C. Remesy Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats J. Nutr. 8 2001 2109 2114
43. M. D'Archivio, C. Filesi, R. Vari, B. Scazzocchio, and R. Masella Bioavailability of the polyphenols: status and controversies Int. J. Mol. Sci. 4 2010 1321 1342
44. A. Dalpiaz, G. Paganetto, B. Pavan, M. Fogagnolo, A. Medici, S. Beggiato, and D. Perrone Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system Mol. Pharm. 4 2012 957 968
45. A.J. Day, and G. Williamson Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma Br. J. Nutr. 2001 S105 S110
46. R. De la Torre, S. De Sola, M. Pons, A. Duchon, M.M. de Lagran, M. Farre, M. Fito, B. Benejam, K. Langohr, J. Rodriguez, M. Pujadas, J.C. Bizot, A. Cuenca, N. Janel, S. Catuara, M.I. Covas, H. Blehaut, Y. Herault, J.M. Delabar, and M. Dierssen Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans Mol. Nutr. Food Res. 2 2014 278 288
47. D.A. Dickinson, K.E. Iles, H. Zhang, V. Blank, and H.J. Forman Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression FASEB J. 3 2003 473 475
48. H. Doi, R. Sakakibara, M. Kishi, Y. Tsuyuzaki, F. Tateno, and S. Hirai Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease Rinsho Shinkeigaku 11 2013 1382 1385
49. J.L. Donovan, J.R. Bell, S. Kasim-Karakas, J.B. German, R.L. Walzem, R.J. Hansen, and A.L. Waterhouse Catechin is present as metabolites in human plasma after consumption of red wine J. Nutr. 9 1999 1662 1668
50. G.G. Duthie, M.W. Pedersen, P.T. Gardner, P.C. Morrice, A.M. Jenkinson, D.B. McPhail, and G.M. Steele The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers Eur. J. Clin. Nutr. 10 1998 733 736
51. R.D. Egleton, S.A. Mitchell, J.D. Huber, J. Janders, D. Stropova, R. Polt, H.I. Yamamura, V.J. Hruby, and T.P. Davis Improved bioavailability to the brain of glycosylated Met-enkephalin analogs Brain Res. 1 2000 37 46
52. R.D. Egleton, S.A. Mitchell, J.D. Huber, M.M. Palian, R. Polt, and T.P. Davis Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation J. Pharmacol. Exp. Ther. 3 2001 967 972
53. M.A. El Mohsen, J. Marks, G. Kuhnle, K. Moore, E. Debnam, S. Kaila Srai, C. Rice-Evans, and J.P. Spencer Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats Br. J. Nutr. 1 2006 51 58
54. I. Erlund, T. Kosonen, G. Alfthan, J. Maenpaa, K. Perttunen, J. Kenraali, J. Parantainen, and A. Aro Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers Eur. J. Clin. Pharmacol. 8 2000 545 553
55. I. Erlund, E. Meririnne, G. Alfthan, and A. Aro Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice J. Nutr. 2 2001 235 241
56. C.N. Falany Enzymology of human cytosolic sulfotransferases FASEB J. 4 1997 206 216
57. M.N. Fernandez-Martinez, L. Hernandez-Echevarria, M. Sierra-Vega, M.J. Diez-Liebana, A. Calle-Pardo, D. Carriedo-Ule, A.M. Sahagun-Prieto, A. Anguera-Vila, and J.J. Garcia-Vieitez A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters BMC Complement. Altern. Med. 296 2014
58. N. Fernandez, D. Carriedo, M. Sierra, M.J. Diez, A. Sahagun, A. Calle, A. Gonzalez, and J.J. Garcia Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa Eur. Neuropsychopharmacol. 5 2005 505 509
59. P. Ferri, D. Angelino, L. Gennari, S. Benedetti, P. Ambrogini, P. Del Grande, and P. Ninfali Enhancement of flavonoid ability to cross the blood-brain barrier of rats by co-administration with alpha-tocopherol Food Funct. 2 2015 394 400
60. M.G. Ferruzzi, J.K. Lobo, E.M. Janle, B. Cooper, J.E. Simon, Q.L. Wu, C. Welch, L. Ho, C. Weaver, and G.M. Pasinetti Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease J. Alzheimers Dis. 1 2009 113 124
61. M. Fito, R. de la Torre, M. Farre-Albaladejo, O. Khymenetz, J. Marrugat, and M.I. Covas Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: a review Ann. Ist. Super. Sanita 4 2007 375 381
62. S.C. Forester, and A.L. Waterhouse Metabolites are key to understanding health effects of wine polyphenolics J. Nutr. 9 2009 1824S 1831S
63. R.L. Frozza, A. Bernardi, K. Paese, J.B. Hoppe, T. da Silva, A.M. Battastini, A.R. Pohlmann, S.S. Guterres, and C. Salbego Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats J. Biomed. Nanotechnol. 6 2010 694 703
64. G. Garcea, D.J. Jones, R. Singh, A.R. Dennison, P.B. Farmer, R.A. Sharma, W.P. Steward, A.J. Gescher, and D.P. Berry Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration Br. J. Cancer 5 2004 1011 1015
65. J.J. Garcia, N. Fernandez, D. Carriedo, M.J. Diez, A. Sahagun, A. Gonzalez, A. Calle, and M. Sierra Hydrosoluble fiber (Plantago ovata husk) and levodopa I: experimental study of the pharmacokinetic interaction Eur. Neuropsychopharmacol. 5 2005 497 503
66. S. Gelinas, and M.G. Martinoli Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells J. Neurosci. Res. 1 2002 90 96
67. C.L. Gentry, R.D. Egleton, T. Gillespie, T.J. Abbruscato, H.B. Bechowski, V.J. Hruby, and T.P. Davis The effect of halogenation on blood-brain barrier permeability of a novel peptide drug Peptides 10 1999 1229 1238
68. A. Gjedde High- and low-affinity transport of D-glucose from blood to brain J. Neurochem. 4 1981 1463 1471
69. R. Gordon Resveratrol protects dopaminergic neurons in Parkinson's disease models by modulating the PKC-delta apoptotic signaling pathway & microglial activation Proceedings of FASEB Meeting, 0892-6638, vol. (24:763.5) 2010
70. O.S. Gudmundsson, D.G. Vander Velde, S.D. Jois, A. Bak, T.J. Siahaan, and R.T. Borchardt The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability J. Pept. Res. 4 1999 403 413
71. S. Guo, E. Bezard, and B. Zhao Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway Free Radic. Biol. Med. 5 2005 682 695
72. S. Guo, J. Yan, T. Yang, X. Yang, E. Bezard, and B. Zhao Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway Biol. Psychiatry 12 2007 1353 1362
73. N.K. Gupta, and V.K. Dixit Bioavailability enhancement of curcumin by complexation with phosphatidyl choline J. Pharm. Sci. 5 2011 1987 1995
74. N.K. Gupta, and V.K. Dixit Development and evaluation of vesicular system for curcumin delivery Arch. Dermatol Res. 2 2011 89 101
75. M. Harada, Y. Kan, H. Naoki, Y. Fukui, N. Kageyama, M. Nakai, W. Miki, and Y. Kiso Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin Biosci. Biotechnol. Biochem. 6 1999 973 977
76. J. He, B.A. Magnuson, G. Lala, Q. Tian, S.J. Schwartz, and M.M. Giusti Intact anthocyanins and metabolites in rat urine and plasma after 3 months of anthocyanin supplementation Nutr. Cancer 1 2006 3 12
77. L. Ho, M.G. Ferruzzi, E.M. Janle, J. Wang, B. Gong, T.Y. Chen, J. Lobo, B. Cooper, Q.L. Wu, S.T. Talcott, S.S. Percival, J.E. Simon, and G.M. Pasinetti Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease FASEB J. 2 2013 769 781
78. R.R. Hou, J.Z. Chen, H. Chen, X.G. Kang, M.G. Li, and B.R. Wang Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells Cell. Biol. Int. 1 2008 22 30
79. J. Husch, J. Bohnet, G. Fricker, C. Skarke, C. Artaria, G. Appendino, M. Schubert-Zsilavecz, and M. Abdel-Tawab Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome((R))) of Boswellia extract Fitoterapia 2013 89 98
80. M.O. Iwunze, and D. McEwan Peroxynitrite interaction with curcumin solubilized in ethanolic solution Cell. Mol. Biol. (Noisy-le-grand) 6 2004 749 752
81. B. Jagatha, R.B. Mythri, S. Vali, and M.M. Bharath Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies Free Radic. Biol. Med. 5 2008 907 917
82. E.M. Janle, M.A. Lila, M. Grannan, L. Wood, A. Higgins, G.G. Yousef, R.B. Rogers, H. Kim, G.S. Jackson, L. Ho, and C.M. Weaver Pharmacokinetics and tissue distribution of 14C-labeled grape polyphenols in the periphery and the central nervous system following oral administration J. Med. Food 4 2010 926 933
83. W.A. Jefferies, M.R. Brandon, S.V. Hunt, A.F. Williams, K.C. Gatter, and D.Y. Mason Transferrin receptor on endothelium of brain capillaries Nature 5990 1984 162 163
84. Y. Jiao, J.t. Wilkinson, E. Christine Pietsch, J.L. Buss, W. Wang, R. Planalp, F.M. Torti, and S.V. Torti Iron chelation in the biological activity of curcumin Free Radic. Biol. Med. 7 2006 1152 1160
85. Y. Jiao, J.t. Wilkinson, X. Di, W. Wang, H. Hatcher, N.D. Kock, R. D'Agostino Jr., M.A. Knovich, F.M. Torti, and S.V. Torti Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator Blood 2 2009 462 469
86. F. Jin, Q. Wu, Y.F. Lu, Q.H. Gong, and J.S. Shi Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats Eur. J. Pharmacol. 1-3 2008 78 82
87. J. Jodoin, M. Demeule, and R. Beliveau Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols Biochim. Biophys. Acta 1-3 2002 149 159
88. K.S. Kang, Y. Wen, N. Yamabe, M. Fukui, S.C. Bishop, and B.T. Zhu Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies PLoS One 8 2010 e11951
89. D.O. Kennedy, E.L. Wightman, J.L. Reay, G. Lietz, E.J. Okello, A. Wilde, and C.F. Haskell Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation Am. J. Clin. Nutr. 6 2010 1590 1597
90. E. Kesse-Guyot, L. Fezeu, V.A. Andreeva, M. Touvier, A. Scalbert, S. Hercberg, and P. Galan Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later J. Nutr. 1 2012 76 83
91. M.M. Khan, A. Ahmad, T. Ishrat, M.B. Khan, M.N. Hoda, G. Khuwaja, S.S. Raza, A. Khan, H. Javed, K. Vaibhav, and F. Islam Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease Brain Res. 2010 139 151
92. P.M. Kidd Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts Altern. Med. Rev. 3 2009 226 246
93. H.S. Kim, M.J. Quon, and J.A. Kim New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate Redox Biol. 2014 187 195
94. J.S. Kim, J.M. Kim, J.J. O, and B.S. Jeon Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease J. Clin. Neurosci. 9 2010 1165 1168
95. S.J. Kim, T.G. Son, H.R. Park, M. Park, M.S. Kim, H.S. Kim, H.Y. Chung, M.P. Mattson, and J. Lee Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus J. Biol. Chem. 21 2008 14497 14505
96. A. King, and G. Young Characteristics and occurrence of phenolic phytochemicals J. Am. Diet. Assoc. 2 1999 213 218
97. S. Kitagawa Inhibitory effects of polyphenols on p-glycoprotein-mediated transport Biol. Pharm. Bull. 1 2006 1 6
98. J. Kreuter, R.N. Alyautdin, D.A. Kharkevich, and A.A. Ivanov Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) Brain Res. 1 1995 171 174
99. R. Krikorian, E.L. Boespflug, D.E. Fleck, A.L. Stein, J.D. Wightman, M.D. Shidler, and S. Sadat-Hossieny Concord grape juice supplementation and neurocognitive function in human aging J. Agric. Food Chem. 23 2012 5736 5742
100. A.K. Kumagai, J.B. Eisenberg, and W.M. Pardridge Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport J. Biol. Chem. 31 1987 15214 15219
101. C.D. Lao, M.T.t. Ruffin, D. Normolle, D.D. Heath, S.I. Murray, J.M. Bailey, M.E. Boggs, J. Crowell, C.L. Rock, and D.E. Brenner Dose escalation of a curcuminoid formulation BMC Complement. Altern. Med. 10 2006
102. M.J. LaVoie, B.L. Ostaszewski, A. Weihofen, M.G. Schlossmacher, and D.J. Selkoe Dopamine covalently modifies and functionally inactivates parkin Nat. Med. 11 2005 1214 1221
103. M.J. Lee, P. Maliakal, L. Chen, X. Meng, F.Y. Bondoc, S. Prabhu, G. Lambert, S. Mohr, and C.S. Yang Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability Cancer Epidemiol. Biomarkers Prev. 10 Pt 1 2002 1025 1032
104. M.K. Lee, S.J. Kang, M. Poncz, K.J. Song, and K.S. Park Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine Exp. Mol. Med. 3 2007 376 384
105. S. Lesser, R. Cermak, and S. Wolffram Bioavailability of quercetin in pigs is influenced by the dietary fat content J. Nutr. 6 2004 1508 1511
106. M.H. Leung, H. Colangelo, and T.W. Kee Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis Langmuir 11 2008 5672 5675
107. Y. Levites, T. Amit, M.B. Youdim, and S. Mandel Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action J. Biol. Chem. 34 2002 30574 30580
108. Y. Levites, O. Weinreb, G. Maor, M.B. Youdim, and S. Mandel Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration J. Neurochem. 5 2001 1073 1082
109. L. Li, B. Ahmed, K. Mehta, and R. Kurzrock Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer Mol. Cancer Ther. 4 2007 1276 1282
110. L. Li, F.S. Braiteh, and R. Kurzrock Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis Cancer 6 2005 1322 1331
111. R. Li, Y.G. Huang, D. Fang, and W.D. Le (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury J. Neurosci. Res. 5 2004 723 731
112. R. Li, N. Peng, F. Du, X.P. Li, and W.D. Le Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation Nan Fang. Yi Ke Da Xue Xue Bao 4 2006 376 380
113. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J. Neurosci. 21 2001 8370 8377
114. A. Liu, H. Lou, L. Zhao, and P. Fan Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin J. Pharm. Biomed. Anal. 3 2006 720 727
115. J. Long, H. Gao, L. Sun, J. Liu, and X. Zhao-Wilson Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model Rejuvenation Res. 5 2009 321 331
116. F. Lu, M. Zahid, C. Wang, M. Saeed, E.L. Cavalieri, and E.G. Rogan Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells Cancer Prev. Res. (Phila) 2 2008 135 145
117. Y. Luo, A. Hattori, J. Munoz, Z.H. Qin, and G.S. Roth Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats Mol. Pharmacol. 2 1999 254 264
118. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin J. Biomed. Mater. Res. A 2 2008 300 310
119. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clin. Nutr. 5 2004 727 747
120. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 1 Suppl. l 2005 230S 242S
121. S. Mandel, G. Maor, and M.B. Youdim Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate J. Mol. Neurosci. 3 2004 401 416
122. S.A. Mandel, T. Amit, L. Kalfon, L. Reznichenko, and M.B. Youdim Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins J. Nutr. 8 2008 1578S 1583S
123. S.A. Mandel, T. Amit, O. Weinreb, and M.B. Youdim Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases J. Alzheimers Dis. 25 2011 187 208
124. J. Marrugat, M.I. Covas, M. Fito, H. Schroder, E. Miro-Casas, E. Gimeno, M.C. Lopez-Sabater, R. de la Torre, and M. Farre Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation - a randomized controlled trial Eur. J. Nutr. 3 2004 140 147
125. A. Masoumi, B. Goldenson, S. Ghirmai, H. Avagyan, J. Zaghi, K. Abel, X. Zheng, A. Espinosa-Jeffrey, M. Mahanian, P.T. Liu, M. Hewison, M. Mizwickie, J. Cashman, and M. Fiala 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients J. Alzheimers Dis. 3 2009 703 717
126. Y. Mei, F. Qian, D. Wei, and J. Liu Reversal of cancer multidrug resistance by green tea polyphenols J. Pharm. Pharmacol. 10 2004 1307 1314
127. C. Menard, S. Bastianetto, and R. Quirion Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma Front. Cell. Neurosci. 281 2013
128. X. Meng, M.J. Lee, C. Li, S. Sheng, N. Zhu, S. Sang, C.T. Ho, and C.S. Yang Formation and identification of 4'-O-methyl-(-)-epigallocatechin in humans Drug Metab. Dispos. 6 2001 789 793
129. Y. Mousavi, and H. Adlercreutz Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture J. Steroid Biochem. Mol. Biol. 3-8 1992 615 619
130. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives J. Control Release 3 2008 193 209
131. R.B. Mythri, and M.M. Bharath Curcumin: a potential neuroprotective agent in Parkinson's disease Curr. Pharm. Des. 1 2012 91 99
132. R.B. Mythri, G. Harish, S.K. Dubey, K. Misra, and M.M. Bharath Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease Mol. Cell. Biochem. 1-2 2011 135 143
133. R.B. Mythri, G. Harish, N. Raghunath, and M.M. Srinivas Bharath Therapeutic potential of polyphenols in Parkinson's disease D.I. Finkelstein, Towards New Therapies for Parkinson's Disease 2012 Intech open access Publisher Rijeka, CROATIA 115 150
134. M. Natsume, N. Osakabe, M. Oyama, M. Sasaki, S. Baba, Y. Nakamura, T. Osawa, and J. Terao Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat Free Radic. Biol. Med. 7 2003 840 849
135. W.H. Oldendorf, and J. Szabo Amino acid assignment to one of three blood-brain barrier amino acid carriers Am. J. Physiol. 1 1976 94 98
136. K. Ono, and M. Yamada Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro J. Neurochem. 1 2006 105 115
137. M.M. Palian, and R. Polt Lipo alpha-amino-beta-hydroxy acids and O-linked glycosides: building blocks for ceramyl and glycosphingoyl peptides J. Org. Chem. 21 2001 7178 7183
138. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab. Dispos. 4 1999 486 494
139. T. Pan, J. Jankovic, and W. Le Potential therapeutic properties of green tea polyphenols in Parkinson's disease Drugs Aging 10 2003 711 721
140. N. Pandey, J. Strider, W.C. Nolan, S.X. Yan, and J.E. Galvin Curcumin inhibits aggregation of alpha-synuclein Acta Neuropathol. 4 2008 479 489
141. W.M. Pardridge, J.L. Buciak, and P.M. Friden Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo J. Pharmacol. Exp. Ther. 1 1991 66 70
142. Y. Patil, and J. Panyam Polymeric nanoparticles for siRNA delivery and gene silencing Int. J. Pharm. 1-2 2009 195 203
143. F. Pinnen, I. Cacciatore, C. Cornacchia, A. Mollica, P. Sozio, L.S. Cerasa, A. Iannitelli, A. Fontana, C. Nasuti, and A. Di Stefano CNS delivery of L-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug Amino Acids 1 2012 261 269
144. M.K. Piskula, and J. Terao Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues J. Nutr. 7 1998 1172 1178
145. J.F. Poduslo, and G.L. Curran Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy Proc. Natl. Acad. Sci. U S A 6 1992 2218 2222
146. J.F. Poduslo, and G.L. Curran Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers Brain Res. Mol. Brain Res. 1-2 1994 157 162
147. K.I. Priyadarsini, D.K. Maity, G.H. Naik, M.S. Kumar, M.K. Unnikrishnan, J.G. Satav, and H. Mohan Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin Free Radic. Biol. Med. 5 2003 475 484
148. S. Qureshi, A.H. Shah, and A.M. Ageel Toxicity studies on Alpinia galanga and Curcuma longa Planta Med. 2 1992 124 127
149. A. Rajeswari Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Eur. Rev. Med. Pharmacol. Sci. 4 2006 157 161
150. J. Ravindran, H.B. Nair, B. Sung, S. Prasad, R.R. Tekmal, and B.B. Aggarwal Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential Biochem. Pharmacol. 11 2010 1640 1647
151. B. Ray, S. Bisht, A. Maitra, A. Maitra, and D.K. Lahiri Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: implications for Alzheimer's disease J. Alzheimers Dis. 1 2011 61 77
152. H. Raza, A. John, E.M. Brown, S. Benedict, and A. Kambal Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells Toxicol. Appl. Pharmacol. 2 2008 161 168
153. A.R. Rechner, M.A. Smith, G. Kuhnle, G.R. Gibson, E.S. Debnam, S.K. Srai, K.P. Moore, and C.A. Rice-Evans Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products Free Radic. Biol. Med. 2 2004 212 225
154. T. Richard, A.D. Pawlus, M.L. Iglesias, E. Pedrot, P. Waffo-Teguo, J.M. Merillon, and J.P. Monti Neuroprotective properties of resveratrol and derivatives Ann. N. Y. Acad. Sci. 2011 103 108
155. M.F. Ritz, P. Ratajczak, Y. Curin, E. Cam, A. Mendelowitsch, F. Pinet, and R. Andriantsitohaina Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke J. Nutr. 3 2008 519 525
156. A. Sahu, U. Bora, N. Kasoju, and P. Goswami Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells Acta Biomater. 6 2008 1752 1761
157. P. Saiko, A. Szakmary, W. Jaeger, and T. Szekeres Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat. Res. 1-2 2008 68 94
158. D.F. Sargent, J.W. Bean, and R. Schwyzer Conformation and orientation of regulatory peptides on lipid membranes. Key to the molecular mechanism of receptor selection Biophys. Chem. 1-2 1988 183 193
159. H. Sawada, M. Ibi, T. Kihara, K. Honda, T. Nakamizo, R. Kanki, M. Nakanishi, N. Sakka, A. Akaike, and S. Shimohama Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model Neuropharmacology 8 2002 1056 1064
160. M. Sazuka, T. Itoi, Y. Suzuki, S. Odani, T. Koide, and M. Isemura Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein Biosci. Biotechnol. Biochem. 8 1996 1317 1319
161. A. Scalbert, and G. Williamson Dietary intake and bioavailability of polyphenols J. Nutr. 8S Suppl. l 2000 2073S 2085S
162. A. Scheepens, K. Tan, and J.W. Paxton Improving the oral bioavailability of beneficial polyphenols through designed synergies Genes. Nutr. 1 2010 75 87
163. A. Scholey, L.A. Downey, J. Ciorciari, A. Pipingas, K. Nolidin, M. Finn, M. Wines, S. Catchlove, A. Terrens, E. Barlow, L. Gordon, and C. Stough Acute neurocognitive effects of epigallocatechin gallate (EGCG) Appetite 2 2012 767 770
164. E. Scoditti, A. Nestola, M. Massaro, N. Calabriso, C. Storelli, R. De Caterina, and M.A. Carluccio Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCalpha and PKCbeta1 inhibition Atherosclerosis 1 2014 17 24
165. A. Semalty, M. Semalty, M.S. Rawat, and F. Franceschi Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals Fitoterapia 5 2010 306 314
166. K.D. Setchell, N.M. Brown, and E. Lydeking-Olsen The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J. Nutr. 12 2002 3577 3584
167. K.D. Setchell, M.S. Faughnan, T. Avades, L. Zimmer-Nechemias, N.M. Brown, B.E. Wolfe, W.T. Brashear, P. Desai, M.F. Oldfield, N.P. Botting, and A. Cassidy Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women Am. J. Clin. Nutr. 2 2003 411 419
168. K.D. Setchell, A.M. Lawson, E. Conway, N.F. Taylor, D.N. Kirk, G. Cooley, R.D. Farrant, S. Wynn, and M. Axelson The definitive identification of the lignans trans-2,3-bis(3-hydroxybenzyl)-gamma-butyrolactone and 2,3-bis(3-hydroxybenzyl)butane-1,4-diol in human and animal urine Biochem. J. 2 1981 447 458
169. T.N. Shankar, N.V. Shantha, H.P. Ramesh, I.A. Murthy, and V.S. Murthy Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys Indian J. Exp. Biol. 1 1980 73 75
170. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med. 4 1998 353 356
171. A.L. Simons, M. Renouf, S. Hendrich, and P.A. Murphy Metabolism of glycitein (7,4'-dihydroxy-6-methoxy-isoflavone) by human gut microflora J. Agric. Food Chem. 22 2005 8519 8525
172. X.R. Song, Z. Cai, Y. Zheng, G. He, F.Y. Cui, D.Q. Gong, S.X. Hou, S.J. Xiong, X.J. Lei, and Y.Q. Wei Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles Eur. J. Pharm. Sci. 3-4 2009 300 305
173. R. Spector, and C.E. Johanson The mammalian choroid plexus Sci. Am. 5 1989 68 74
174. J.P. Spencer Metabolism of tea flavonoids in the gastrointestinal tract J. Nutr. 10 2003 3255S 3261S
175. J.P. Spencer, G. Chowrimootoo, R. Choudhury, E.S. Debnam, S.K. Srai, and C. Rice-Evans The small intestine can both absorb and glucuronidate luminal flavonoids FEBS Lett. 2 1999 224 230
176. D. Suresh, and K. Srinivasan Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats Indian J. Med. Res. 2010 682 691
177. H. Susaki, K. Suzuki, H. Yamada, S. Okuno, and H.K. Watanabe Renal targeting of arginine-vasopressin by modification with carbohydrates at the tyrosine side chain Biol. Pharm. Bull. 10 1999 1094 1098
178. M. Thiyagarajan, and S.S. Sharma Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats Life Sci. 8 2004 969 985
179. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang Formulation and characterization of curcuminoids loaded solid lipid nanoparticles Int. J. Pharm. 1-2 2007 299 306
180. T.H. Tsai Determination of naringin in rat blood, brain, liver, and bile using microdialysis and its interaction with cyclosporin a, a p-glycoprotein modulator J. Agric. Food Chem. 23 2002 6669 6674
181. O. Vajragupta, P. Boonchoong, H. Watanabe, M. Tohda, N. Kummasud, and Y. Sumanont Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity Free Radic. Biol. Med. 12 2003 1632 1644
182. V. Vingtdeux, L. Giliberto, H. Zhao, P. Chandakkar, Q. Wu, J.E. Simon, E.M. Janle, J. Lobo, M.G. Ferruzzi, P. Davies, and P. Marambaud AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism J. Biol. Chem. 12 2010 9100 9113
183. F. Visioli, C. Galli, S. Grande, K. Colonnelli, C. Patelli, G. Galli, and D. Caruso Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration J. Nutr. 8 2003 2612 2615
184. T. Walle Absorption and metabolism of flavonoids Free Radic. Biol. Med. 7 2004 829 837
185. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 12 2004 1377 1382
186. F. Wang, X. Wu, F. Wang, S. Liu, Z. Jia, and J. Yang The sensitive fluorimetric method for the determination of curcumin using the enhancement of mixed micelle J. Fluoresc. 1 2006 53 59
187. J. Wang, W. Bi, A. Cheng, D. Freire, P. Vempati, W. Zhao, B. Gong, E.M. Janle, T.Y. Chen, M.G. Ferruzzi, J. Schmeidler, L. Ho, and G.M. Pasinetti Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications Front. Aging Neurosci. 42 2014
188. J. Wang, X.X. Du, H. Jiang, and J.X. Xie Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells Biochem. Pharmacol. 2 2009 178 183
189. M.S. Wang, S. Boddapati, S. Emadi, and M.R. Sierks Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neurosci. 57 2010
190. Y. Wang, H. Xu, Q. Fu, R. Ma, and J. Xiang Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats J. Neurol. Sci. 304 2011 29 34
191. A.L. Waterhouse Wine phenolics Ann. N. Y. Acad. Sci. 2002 21 36
192. E.L. Wightman, C.F. Haskell, J.S. Forster, R.C. Veasey, and D.O. Kennedy Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation Hum. Psychopharmacol. 2 2012 177 186
193. E.L. Wightman, J.L. Reay, C.F. Haskell, G. Williamson, T.P. Dew, and D.O. Kennedy Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation Br. J. Nutr. 2 2014 203 213
194. K.A. Witt, J.D. Huber, R.D. Egleton, M.J. Roberts, M.D. Bentley, L. Guo, H. Wei, H.I. Yamamura, and T.P. Davis Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE) J. Pharmacol. Exp. Ther. 2 2001 848 856
195. A.V. Witte, L. Kerti, D.S. Margulies, and A. Floel Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults J. Neurosci. 23 2014 7862 7870
196. Y. Xu, B. Ku, L. Cui, X. Li, P.A. Barish, T.C. Foster, and W.O. Ogle Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats Brain Res. 2007 9 18
197. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Scope of nanotechnology in ovarian cancer therapeutics J. Ovarian Res. 19 2010
198. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Curcumin nanoformulations: a future nanomedicine for cancer Drug Discov. Today 1-2 2012 71 80
199. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Curcumin nanomedicine: a road to cancer therapeutics Curr. Pharm. Des. 11 2013 1994 2010
200. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy, and G.M. Cole Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 7 2005 5892 5901
201. K.A. Youdim, M.S. Dobbie, G. Kuhnle, A.R. Proteggente, N.J. Abbott, and C. Rice-Evans Interaction between flavonoids and the blood-brain barrier: in vitro studies J. Neurochem. 1 2003 180 192
202. S. Yu, W. Zheng, N. Xin, Z.H. Chi, N.Q. Wang, Y.X. Nie, W.Y. Feng, and Z.Y. Wang Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway Rejuvenation Res. 1 2010 55 64
203. N.M. Zaki Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients Drug Deliv. 4 2014 265 275
204. N.M. Zaki, A. Nasti, and N. Tirelli Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model Macromol. Biosci. 12 2011 1747 1760
205. N.M. Zaki, and N. Tirelli Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting Expert Opin. Drug Deliv. 8 2010 895 913
206. N.M. Zaki, and N. Tirelli Assessment of nanomaterials cytotoxicity and internalization Methods Mol. Biol. 2011 243 259
207. V. Zbarsky, K.P. Datla, S. Parkar, D.K. Rai, O.I. Aruoma, and D.T. Dexter Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease Free Radic. Res. 10 2005 1119 1125
208. F. Zhang, J.S. Shi, H. Zhou, B. Wilson, J.S. Hong, and H.M. Gao Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions Mol. Pharmacol. 3 2010 466 477
209. J. Zhang, Q. Tang, X. Xu, and N. Li Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery Int. J. Pharm. 1 2013 168 174
210. Y. Zhang, S. Hendrich, and P.A. Murphy Glucuronides are the main isoflavone metabolites in women J. Nutr. 2 2003 399 404
211. A. Zhu, X. Wang, and Z. Guo Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent) Nucl. Med. Biol. 6 2001 735 740
212. Y.G. Zhu, X.C. Chen, Z.Z. Chen, Y.Q. Zeng, G.B. Shi, Y.H. Su, and X. Peng Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons Acta Pharmacol. Sin. 12 2004 1606 1612